RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
glycogen synthase kinase 3 beta
Glycogen synthase kinase-3 (GSK3) is a proline-directed serine-threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase (see GYS1, MIM 138570). Two isoforms, alpha (GSK3A; MIM 606784) and beta, show a high degree of amino acid homology (Stambolic and Woodgett, 1994 [PubMed 7980435]). GSK3B is involved in energy metabolism, neuronal cell development, and body pattern formation (Plyte et al., 1992 [PubMed 1333807]).[supplied by OMIM]
|
|
|
||
|---|---|---|---|
| Dorsal striatum |
100
|
||
| Trigeminal ganglion |
97
|
||
| Vomeronasal organ |
90
|
||
| Substantia nigra |
89
|
||
| Preoptic area |
87
|
||
| Cecum |
85
|
|
|
|
||
|---|---|---|---|
| Sorafenib |
100
|
||
| Dimethyl Sulfoxide |
85
|
||
| Bpde |
71
|
||
| Echinomycin |
67
|
||
| Torcetrapib |
65
|
||
| Tacrolimus |
59
|
Individual Studies |
|
|---|---|
|
|
Authors: Zhong Wang, Kevin S Smith, Mark Murphy, Obdulio Piloto, Tim C P Somervaille, Michael L Cleary
Nature 2008 Oct 30Authors: Jean-Martin Beaulieu, Raul R Gainetdinov, Marc G Caron
Annual review of pharmacology and toxicology 2009Thought leaders and organizations working on research involving GSK3B.
conditions: Progressive Supranuclear Palsy
interventions: valproic acid
conditions: Progressive Supranuclear Palsy ; Corticobasal Degeneration
interventions: Lithium
No NextBio groups were found for “GSK3B”.
Be the first to
start
a group and share your interests with others within the NextBio community.